Armata Pharmaceuticals (ARMP) Interest & Investment Income (2018 - 2024)
Armata Pharmaceuticals (ARMP) reported Interest & Investment Income of $221000.0 for Q2 2024, up 380.43% on a YoY basis from $46000.0 in Q3 2023, and up 325.0% sequentially from $52000.0 in Q1 2024.
Armata Pharmaceuticals (ARMP) Interest & Investment Income (2018 - 2024) Analysis & Trends
Armata Pharmaceuticals (ARMP) has 7 years of Interest & Investment Income data on file, last reported at $221000.0 in Q2 2024.
- For the quarter ending Q2 2024, Interest & Investment Income rose 380.43% year-over-year to $221000.0; the trailing twelve-month figure through Jun 2024 stood at $388000.0 (up 345.98% YoY), and the FY2023 full-year result was $179000.0, up 517.24% from the prior year.
- Interest & Investment Income rose to $221000.0 in Q2 2024, from $52000.0 in the prior quarter.
- In the past five years, Interest & Investment Income ranged from a high of $221000.0 in Q2 2024 to a low of $1000.0 in Q4 2021.
- A 5-year average of $32125.0 and a median of $11500.0 in 2022 frame the typical range for Interest & Investment Income.
- Across the five-year window, Interest & Investment Income tumbled 95.83% in 2020 and soared 1700.0% in 2023, its largest moves.
- Tracing ARMP's Interest & Investment Income over 5 years: stood at $4000.0 in 2020, then tumbled by 75.0% to $1000.0 in 2021, then surged by 1300.0% to $14000.0 in 2022, then surged by 385.71% to $68000.0 in 2023, then jumped by 225.0% to $221000.0 in 2024.
- Business Quant data shows ARMP's Interest & Investment Income at $221000.0 in Q2 2024, $52000.0 in Q1 2024, and $68000.0 in Q4 2023.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Int & Inv Inc (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,621.14 Bn | 66,620.85 Bn | - | - |
| 2 | Nanobiotix | 1,915.18 Bn | 1,915.11 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | - |
| 4 | BeOne Medicines | 471.27 Bn | 466.48 Bn | 1.35 Bn | 27.66 Mn |
| 5 | Vertex Pharmaceuticals | 121.81 Bn | 114.57 Bn | 2.59 Bn | 114.80 Mn |
| 6 | Regeneron Pharmaceuticals | 69.58 Bn | 60.82 Bn | 3.31 Bn | -65.80 Mn |
| 7 | Belite Bio | 62.72 Bn | 62.72 Bn | - | - |
| 8 | Argenx Se | 55.51 Bn | 50.33 Bn | 1.41 Bn | 48.00 Mn |
| 9 | Revolution Medicines | 37.35 Bn | 37.35 Bn | - | 19.51 Mn |
| 10 | Armata Pharmaceuticals | 187.95 Mn | 183.15 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2024 | 221,000.00 |
| Mar 31, 2024 | 52,000.00 |
| Dec 31, 2023 | 68,000.00 |
| Sep 30, 2023 | 47,000.00 |
| Jun 30, 2023 | 46,000.00 |
| Mar 31, 2023 | 18,000.00 |
| Dec 31, 2022 | 14,000.00 |
| Sep 30, 2022 | 9,000.00 |
| Jun 30, 2022 | 5,000.00 |
| Mar 31, 2022 | 1,000.00 |
| Dec 31, 2021 | 1,000.00 |
| Jun 30, 2021 | 2,000.00 |
| Mar 31, 2021 | 2,000.00 |
| Sep 30, 2020 | 4,000.00 |
| Jun 30, 2020 | 22,000.00 |
| Mar 31, 2020 | 2,000.00 |
| Dec 31, 2019 | 7,000.00 |
| Sep 30, 2019 | 13,000.00 |
| Jun 30, 2019 | 28,000.00 |
| Mar 31, 2019 | 48,000.00 |